Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants

Giovanni Vento, Costantino Romagnoli, Xavier Durrmeyer, Helmut Hummler, Manuel Sanchez-Luna, Virgilio P. Carnielli, David Field, Anne Greenough, Bart Van Overmeire, Baldvin Jonsson, Mikko Hallman, Jean-Christophe Mercier, Neil Marlow, Samantha Johnson, James Baldassarre

Risultato della ricerca: Contributo in rivistaArticolo in rivista

10 Citazioni (Scopus)

Abstract

The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitric oxide (iNO) compared with placebo in infants with respiratory failure. This follow-up study evaluated respiratory, neurodevelopmental, and other outcomes for infants entered into the European Union Nitric Oxide trial to age 2 years.
Lingua originaleEnglish
pagine (da-a)e695-e703
RivistaPediatrics
Volume132
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • Administration, Inhalation
  • Bronchodilator Agents
  • Child, Preschool
  • European Union
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Nitric Oxide
  • Respiratory Distress Syndrome, Newborn
  • Survival Rate
  • developmental outcomes
  • growth
  • inhaled nitric oxide
  • premature infants
  • randomized controlled trial

Fingerprint Entra nei temi di ricerca di 'Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants'. Insieme formano una fingerprint unica.

Cita questo